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Abstract: 
Background: In non-anemic pregnant women recommended a daily intake of iron supplementation. This study 
aimed to determine the effects of daily iron supplementation versus twice a week in non-anemic pregnant women on 
pregnancy outcome. 
Material and method:: In this double- blind randomized clinical trial study 508 pregnant women with Hb> 11mg/dl 
and serum ferritin 10-300 ng/dl in first half of pregnancy were randomly divided to receive either of 1 table/day [50 
mg elemental] ferrous sulphate[n=254], or two tablet per weeks[n=254]. Haemoglobin, ferritin and glucose 
challenge test were measured in the 24-28th weeks and at the end of pregnancy. Patient information was recorded 
and analysed for haemoglobin, insulin, and ferritin. Data were analysed using independent-t test, ANOVA, and Chi 
square tests. 
Results: The risk of preeclampsia and low birth weight significantly increased in the groups with daily intake of iron 
supplements. In addition, the levels of FBS, insulin and blood-pressure rise significantly in the second trimester. We 
should also note that the mean ferritin levels were significantly higher in cases with low birth weight and pre-
eclampsia. 
Conclusion: The daily supplementation of iron significantly increased preeclampsia and low birth weight in non-
anaemic pregnant women which is associated with high level of ferritin in patient 
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INTRODUCTION:  
The need for iron during pregnancy to increase the 
mass of red blood cells, the blood supply to the 
developing fetus and placenta is necessary [1] Iron 
deficiency can be associated with morbidity and 
preterm delivery [2]. WHO recommended iron 
supplement in pregnancy [3], the prevalence of iron 
deficiency anaemia in pregnant women in Iran, 
according to WHO definitions are between 3.4-
5.21% [4] According to Iranian health ministry 
protocol, pregnant women from 12-17 weeks till  3 
months after delivery should intake 30 mg elemental 
iron tablets [5]. Recently, studies in relation to the 
daily consumption of iron supplementation in Non-
anaemic pregnant women and its complications, 
questioned daily consumption of iron 
supplementation. 
New evidence has shown the effects of iron 
supplements on production of free radical and 
oxidative stress [6-7].some studies show that 
increased ferritin and iron levels are associated with 
gestational diabetes, low birth weight and increased 
risks of pregnancy [9-11].In some countries using 
iron supplementation is not routine [8] Thus, 
according to available reports, the aim of this clinical 
trial was to assess the effects of daily iron 
supplements versus 2 times a week in Non-anaemic 
pregnant women on pregnancy and perinatal 
outcome.    
 
MATERIALS AND METHODS: 
This study was a randomized, double-blind clinical 
trial that has been done on singleton pregnancy 
.women attending in prenatal clinic of Yas Hospital 
during the years 2009-2010. Inclusion criteria were: 
Non-smoking, No history of (asthma, chronic 
hypertension leads to polycythaemia, gestational 
diabetes, preeclampsia and overt diabetes), No use of 
glucocorticoid and sympathomimetic drugs. After 
confirming the research in the ethics committee of 
Tehran University of Medical Sciences with the code; 
2400 the  project was explained to each individual 
and written consent obtained.  Eligible individuals 
were randomly divided into two groups. Random 
method was so that according to entering the hospital 
and after being qualified for inclusion, individuals 
were randomly assigned to groups A and B, this 
process continued until the completion of the sample. 
Ferrous sulphate supplements from doctor Abidi 
pharmaceutical company was prepared and delivered 
to the individual. Haemoglobin test was done using 
Sian Matt haemoglobin and a Coulter Counter 
(Model 2001 - Made in America).The definition of 
variables in this study were as follows: Diagnosis of 
gestational diabetes - At gestational age of 24-28 
weeks GCT (testing glucose 1 hour after intake of 50 
grams edible Glucose), was done and if GCT was 
equal or higher of 130 mg per/dl, the GTT Test was 
done (4 times blood sugar test were done in which 
including fasting plasma glucose, and 1, 2 and 3 
hours after consumption of 100 grams of glucose) if 2 
items of measurement were abnormal ( FBS ≥95, 
1h≥180, 2h≥155, 3h≥140 ) diagnosis of gestational 
diabetes was confirmed. Preeclampsia was a checked 
at 24-28 and 32-36weeks for patients with blood 
pressure and random urine protein. If there was a 
blood pressure equal to or higher than 140/90 mm Hg 
and urine protein+1 or higher, preeclampsia was 
approved. Low birth weight- In all patients after 
delivery, birth weight of 2500 grams or less weight,  
was confirmed as low birth weight. 
In Gestational age of less than 18 weeks, , 508 
patients were selected and divided into 2 groups, 
early CBC and serum ferritin levels have been 
checked and individuals with Hb 11 -13 g /dl and 
serum ferritin level of 10 -300 ng / ml interred the 
study. Group (A) were given daily one 50 mg 
elemental ferrous sulphate tablet  from week of 20, 
and group (B) received 2 tablets elemental ferrous 
sulphate a week. In the gestational age of 24- 
28weeks, CBC and serum ferritin, blood pressure, 
glucose tolerance test (GCT) and random urine 
protein were checked and if GCT≥ 130 mg / dl, GTT 
was done. At the gestational age of 32-36weeks the 
CBC and serum ferritin level were checked again. All 
patients have been checked for birth weight at 
delivery.  
 
RESULTS:  
Our results showed that among all 72 patients with 
GDM, 55 patients (76%) were in the A group and 17 
patients (24%) in the B group  p< 0.001 (Table 1). In 
total, those 69 patients with preeclampsia, 53 patients 
(77%) placed in the group A and 16 patients (23%) in 
the group B  p< 0.001 (Table 1). Ferritin level is 
significantly higher in patients with pre-eclampsia 
(Table 2). Ferritin in the first, second and third 
trimester in the women with low birth weight infants 
was significantly higher (Table 3).  
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Table 1.variables and iron status in the study groups 
 
 
Fe  95% Confidence Interval P value 
daily Two in week 
Odds Ratio 
 lower Upper 
Preeclampsia 
 
53 
 
16 0.255 0.141 0.46 0.001 
76.80% 23.20% 
low Birth weight=<2500 gr 
 
43 
 
11 0.222 0.112 0.442 0.001 
79.60% 20.40% 
Serum insulin level in 
second trimester > 20 
 
55 
 
17 0.258 0.145 0.46 0.001 
76.40% 23.60% 
Abnormal GTT 
 
49 
 
17 0.3 0.168 0.537 0.001 
74.20% 25.80% 
Serum ferritin level ≥300 
ng/ml 
 
40 
 
10 0.202 0.099 0.415 0.001 
80.00% 20.00% 
 
Table 2.variables and iron status in the study groups in at women with preeclampsia 
 
 daily two in weeks 
 Mean Mean p value 
Hb[g/dl] [under 20 weeks] 12.8±.60 12.7±.14 0.178 
Fri[Ng/ml][under 20 weeks] 135.6±52.7 120.3±43.1 0.0001 
Hb[g/dl] [24-28 Weeks] 12.5±.60 12.4±.70 0.799 
Fri [Ng/ml][24-28 Weeks] 273.8±91.0 287.7±69.2 0.0001 
insulin [mg/dl][24-28 Weeks] 15.3±6.9 13.0±3.4 0.001 
GCT[mg/dl][24-28 Weeks] 110.7±15.3 107.8±12.2 0.007 
Hb [g/dl][32-36 Weeks] 12.7±.4 12.6±.3 0.78 
Fri[Ng/ml] [32-36 Weeks] 278.4±102.1 280.2±109.5 0.0001 
birth weight[gr] 2798.2±945.6 2952.6±832.0 0.0001 
 
Table 3.variables and iron status in the study groups at women with LBW 
 
 daily two in weeks p value  
 Mean Mean  
Hb[g/dl] [under 20 weeks] 12.7±.5 12.8±.5 0.295 
Fri[Ng/ml][under 20 weeks] 94.7±43.9 125.3±77.1 0.0001 
Hb[g/dl] [24-28 Weeks] 12.5±.5 12.6±.6 0.343 
Fri [Ng/ml][24-28 Weeks] 180.9±115.8 192.4±128.24 0.0001 
Insulin [mg/dl][24-28 Weeks] 15.5±7.0 13.6±2.5 0.008 
GCT[mg/dl][24-28 Weeks] 108.9± 12.6 108.1±19.6 0.009 
Hb [g/dl][32-36 Weeks] 12.8±.5 12.6±.5 0.78 
Fri[Ng/ml] [32-36 Weeks] 153.2±103.2 245.0±192.4 0.0001 
Birth weight[gr] 1779.2±606.7 1683.0±553.2 0.0001 
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DISCUSSION: 
In this clinical trial, the effect of iron 
supplementation on preeclampsia and birth weight 
was studied. Our results showed that daily iron 
supplementation significantly increased preeclampsia 
and low birth weight in Non-anaemic women. Iron 
supplementation in women without iron-deficiency 
anaemia can increases the risk of pregnancy 
complication. Our results are in agreement with some 
other studies which showed that daily iron basis can 
significantly increase preeclampsia and low birth 
weight [10-9] 
Today, all healthy and iron deficiency anaemia 
pregnant women are given iron supplements [5].So it 
seems that Iron supplement in women with iron 
deficiency has good effect but in women without 
iron-deficiency anaemia it can increase the risk of 
pregnancy. This issue in this study is consistent with 
studies of Scholl in 2005 [12]. As other studies it was 
indicated that haemoglobin of 13.3 grams per litter 
could increase blood pressure [13].In another study 
using130 grams per litter haemoglobin doubled the 
risk of premature birth and low birth weight [10]. 
Reports of Siega-Riz in 2006 also argued that Iron 
supplement was useful for anaemic mothers but could 
be harmful to healthy women [14]. There are other 
studies that indicate profits and losses of iron 
supplements in healthy women leaving to do more 
research projects [12].According to Jiang in 2004 that 
was published in JAMA, the high iron stores 
increased the risk of diabetes in women with no risk 
factors for diabetes [15].In Goldenberg study, high 
ferritin at 26 weeks was strongly associated with low 
birth weight and preterm delivery [9]. Thus, present 
research studies have confirmed the above results, 
however some variables are slightly different. 
Need to iron in the first and second trimester is 8 mg 
/ day and in the third trimester 6 mg / day [16], 
Normal levels of haemoglobin are 11.7 -13.7g / dl 
and normal haematocrit values are 33-38% in 
pregnant women [17]. Luzm and Murphy have 
questioned about using iron supplement in low-risk 
women [18, 13]. Some studies have investigated the 
effects of an increase in haemoglobin on pregnancy 
outcome. This studies showed the risk of 
hypertension in pregnancy, intrauterine growth 
restriction, low birth weight, premature birth and 
gestational diabetes with high levels of haemoglobin 
[23-19].  
The novelty of this study, along with other research is 
that ferritin and not hemoglobin incensement were 
assayed.  
In 2000 Lao showed that the amount of ferritin has an 
inverse correlation with the fetus weight, the mean of 
fetus weight was significantly lower in the group 
with daily iron intake than the control group, our 
studies also confirms Lao’s results[1]. 
 Ziaei  recognized that the intake of iron causes blood 
pressure in pregnant women [24] iron supplements 
have been linked to increased oxidative stress during 
pregnancy[12]. In consonance with this study related 
high ferritin with preeclampsia. According to the 
previous researches and the present results, we do not 
recommend a daily dose of iron. There are some 
debates between the related articles on the pregnancy 
outcome. For example in Yongh et al.  Studies [25] 
on anaemic women and Casanveva et al. studies on 
no anaemic women [26] weekly regimes are 
considerd superior to daily ones.In the findings of 
Pena-Rosas et al in review article show, [11] the 
daily supplementation of iron plus folic acid produces 
similar primary infant outcomes as the intermittent 
iron plus folic acid regimens (Outcomes such as, low 
birth weight (average risk ratio (RR) 0.96; 95% 
confidence interval (CI) 0.61 to 1.52, seven studies), 
infant birth weight (mean difference MD -8.62 g; 
95% CI -52.76 g to 35.52 g, eight studies), premature 
birth (average RR 1.82; 95% CI 0.75 to 4.40, four 
studies). On the other hand, the intermittent regimens 
are associated with fewer side effects for the mothers, 
namely the average RR and the risk of developing 
high HB concentrations during the second or third 
trimester of pregnancy. They also note that those who 
took daily supplements of iron plus folic acid had 
increased risk of high levels of HB in mid and late 
pregnancy but were less likely to show mild anemia 
near term. Therefore it’s been suggested that 
intermittent regimen may be a practical alternative to 
daily iron supplementation among those pregnant 
women whom are not anemic and have sufficient 
antenatal care. Whereas, in our studies we observed 
that Groups on a daily iron had a significantly higher 
risk of pre-eclampsia and low birth weight. Also 
notable is the remarkably higher FBS, insulin and 
high blood pressure in pregnant women in their 
second trimester. In addition, ferritin in the second 
and third trimester was notably greater in low birth 
weight. Mean ferritin levels were significantly higher 
in patients with preeclampsia[27]in 2015 a trial by 
alizade.L etal was conducted on 86 non anemic 
pregnant women (an experimental group with daily 
50mg iron tablet and control group with placebo) to 
compared incidence of anemia and LBW as a 
pregnancy outcome. They showed that iron 
supplementation is not necessary in non anemic 
pregnant women during their pregnancy[28].  
However in our study a larger sample size of non-
anemic pregnant women was investigated and the 
result showed there is statistically significant 
difference on pregnancy outcomes between group 
with two 50mg tablet per week and group with daily 
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50mg iron tablet[28]. Hemminki  et al. at  2016  
shows a pragmatic randomizer controlled clinical 
trial in pregnant women(>18 years old; non high-rise 
pregnancy ) were randomly  allocated to routine iron 
(receiving 60mg ferrous  sulphate plus 400 
microgram folic acid daily) and selective iron 
(receiving 1mg of folic acid per day). The results 
showed that two policies of giving iron to pregnant 
women either as routine supplementation  to 
everyone or treating only women with low Hb has 
similar health outcomes during pregnancy and at 
birth, however women death during pregnancy were 
more common in selective group than in the routine 
group but in subgroup analysis number of deaths in 
the selective group did not differ by Hb levels and it 
is unclear whether the deaths number differences was 
due to intervention, other factors or chance finding. 
[29] 
The prevalence of low birth weight infants in the 
whole study was 11% of all the 508 patients , this 
prevalence was 16% for the 254 patients with daily 
iron intake and 4% for the other 254 patients with a 
iron intake of twice a week. 
 Studies reports that the LBW prevalence in Iran is 
4.1%-11.8% [30-33]. According to the figures 
published so far in Iran, the incidence of LBW 
infants in people with daily iron diet appears high. 
The several studies that have been done in this area 
gave different results. Cogwell et al. (1998) argued 
that iron supplement increased the child's weight at 
birth[34]. Hemminki and colleagues in 1991, showed 
similar results for non-anemic pregnant women who 
take 100mg iron tablets regularly compare with 
pregnant women  who took iron occasionally[35]. In 
2001 Rusmussen due to present debate, claimd the 
necessity of more carefully studies in iron 
relationship between birth weights. It is necessary to 
note that some of these old studies had been done on 
anemic women [36].Consistent with our study 
confirmation, there are many studies that can 
generalize our results. .Rodenberg confirmed the 
study of the relationship between maternal serum Hb 
level and Ferritin  with weight and height neonatal 
[37]Goldenberg Studies [9]Tamura[38] have shown 
the inverse relationship between serum ferritin level 
and birth weight. Allen considered this as mother's 
body infection result [39].Sieg-Riz and Ziaei studies 
in 2006 and 2007 [14, 24] showed the effect of iron 
supplement in non-Anemic women for small size, 
time of delivery and low birth weight in which the 
low birth weight is consistent with our studies. The 
study of Sieg-Riz was a comparison between a group 
without iron and also a group getting 30 mg of iron 
also Ziaei study compared groups without iron and a 
group receiving 50 mg iron per day, which should be 
noted as a difference in generalizing of our results. 
Scalon research in 2000, showed SGA associated 
with hemoglobin concentration above 14.9 mg/dl 
treatment at 12 weeks was and the risk of SGA 1.27 
times and in 14.4 mg /dl this risk increased to 1.79 
times[40].Lewis in 2002 and 2001 on animal models 
showed that high dose iron in RAT caused low birth 
weight [41,42]. More recent studies confirms the 
results of our study and the effect of high-dose iron 
on low birth weight [43,44]. 
 
CONCLUSION:  
Our results showed that using daily iron 
supplementation in non-anaemic pregnant women 
significantly increase preeclampsia and low birth 
weight. This finding can help us in managing on 
pregnant women and can be considered in the 
mother's prenatal care. 
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